↓ Skip to main content

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

Overview of attention for article published in JAMA Ophthalmology, October 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
3 news outlets
twitter
25 X users
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
297 Dimensions

Readers on

mendeley
300 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Published in
JAMA Ophthalmology, October 2018
DOI 10.1001/jamaophthalmol.2018.3255
Pubmed ID
Authors

Jeffrey G. Gross, Adam R. Glassman, Danni Liu, Jennifer K. Sun, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, Michael J. Elman, Frederick L. Ferris, Thomas W. Gardner, Lee M. Jampol, Daniel F. Martin, Michele Melia, Cynthia R. Stockdale, Roy W. Beck

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 300 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 300 100%

Demographic breakdown

Readers by professional status Count As %
Other 34 11%
Researcher 29 10%
Student > Ph. D. Student 25 8%
Student > Doctoral Student 22 7%
Student > Bachelor 22 7%
Other 57 19%
Unknown 111 37%
Readers by discipline Count As %
Medicine and Dentistry 122 41%
Biochemistry, Genetics and Molecular Biology 14 5%
Nursing and Health Professions 9 3%
Agricultural and Biological Sciences 7 2%
Computer Science 5 2%
Other 26 9%
Unknown 117 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#1,063,357
of 25,934,828 outputs
Outputs from JAMA Ophthalmology
#552
of 6,747 outputs
Outputs of similar age
#22,414
of 356,587 outputs
Outputs of similar age from JAMA Ophthalmology
#15
of 97 outputs
Altmetric has tracked 25,934,828 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,747 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,587 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.